130 related articles for article (PubMed ID: 32835737)
1. Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis.
Chalatsa I; Arvanitis N; Arvanitis D; Tsakou AC; Kalantzis ED; Vassiliou AG; Sideris DC; Frakolaki E; Vassilaki N; Vassilacopoulou D
Biochimie; 2020 Oct; 177():78-86. PubMed ID: 32835737
[TBL] [Abstract][Full Text] [Related]
2. L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.
Vassiliou AG; Siaterli MZ; Frakolaki E; Gkogkosi P; Paspaltsis I; Sklaviadis T; Vassilacopoulou D; Vassilaki N
Biochimie; 2019 May; 160():76-87. PubMed ID: 30796964
[TBL] [Abstract][Full Text] [Related]
3. Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.
Vassiliou AG; Fragoulis EG; Vassilacopoulou D
Neurochem Res; 2009 Jun; 34(6):1089-100. PubMed ID: 19005753
[TBL] [Abstract][Full Text] [Related]
4. Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
Kalantzis ED; Scorilas A; Vassilacopoulou D
Curr Pharm Biotechnol; 2018; 19(13):1087-1096. PubMed ID: 30417785
[TBL] [Abstract][Full Text] [Related]
5. Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.
Kokkinou I; Nikolouzou E; Hatzimanolis A; Fragoulis EG; Vassilacopoulou D
Blood Cells Mol Dis; 2009; 42(1):92-8. PubMed ID: 19041269
[TBL] [Abstract][Full Text] [Related]
6. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
Papadopoulos EI; Fragoulis EG; Scorilas A
Gene; 2015 Jan; 554(2):174-80. PubMed ID: 25445287
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristic and physiological role of DOPA-decarboxylase.
Guenter J; Lenartowski R
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1424-1440. PubMed ID: 28100850
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals alternative L-DOPA decarboxylase (DDC) splice variants bearing novel exons, in human hepatocellular and lung cancer cells.
Papatsirou M; Adamopoulos PG; Artemaki PI; Georganti VP; Scorilas A; Vassilacopoulou D; Kontos CK
Gene; 2021 Feb; 768():145262. PubMed ID: 33141052
[TBL] [Abstract][Full Text] [Related]
9. Biochemical identification of residues that discriminate between 3,4-dihydroxyphenylalanine decarboxylase and 3,4-dihydroxyphenylacetaldehyde synthase-mediated reactions.
Liang J; Han Q; Ding H; Li J
Insect Biochem Mol Biol; 2017 Dec; 91():34-43. PubMed ID: 29037755
[TBL] [Abstract][Full Text] [Related]
10. L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of
Tremmel E; Kuhn C; Kaltofen T; Vilsmaier T; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334070
[TBL] [Abstract][Full Text] [Related]
11. A Study for Therapeutic Treatment against Parkinson's Disease via Chou's 5-steps Rule.
Lan J; Liu Z; Liao C; Merkler DJ; Han Q; Li J
Curr Top Med Chem; 2019; 19(25):2318-2333. PubMed ID: 31629395
[TBL] [Abstract][Full Text] [Related]
12. DDC expression is not regulated by NFAT5 (TonEBP) in dopaminergic neural cell lines.
Pineda-Cirera L; Cabana-Domínguez J; Benetó N; Diez H; Arenas C; Cormand B; Fernàndez-Castillo N
Gene; 2020 Jun; 742():144569. PubMed ID: 32165301
[TBL] [Abstract][Full Text] [Related]
13. Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase.
Maneckjee R; Baylin SB
Biochemistry; 1983 Dec; 22(26):6058-63. PubMed ID: 6661425
[TBL] [Abstract][Full Text] [Related]
14. Revised Exon Structure of l-DOPA Decarboxylase (
Artemaki PI; Papatsirou M; Boti MA; Adamopoulos PG; Christodoulou S; Vassilacopoulou D; Scorilas A; Kontos CK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202911
[TBL] [Abstract][Full Text] [Related]
15. L-Dopa decarboxylase expression profile in human cancer cells.
Chalatsa I; Nikolouzou E; Fragoulis EG; Vassilacopoulou D
Mol Biol Rep; 2011 Feb; 38(2):1005-11. PubMed ID: 20535562
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
Fisher A; Starr MS
Brain Res; 2000 Jun; 868(2):268-74. PubMed ID: 10854579
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides modulate dopa decarboxylase function in aromatic l-amino acid decarboxylase deficiency.
Tsai CR; Lee HF; Chi CS; Yang MT; Hsu CC
Hum Mutat; 2018 Dec; 39(12):2072-2082. PubMed ID: 30260058
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches.
Adamopoulos PG; Tsiakanikas P; Kontos CK; Panagiotou A; Vassilacopoulou D; Scorilas A
Gene; 2019 Nov; 719():144075. PubMed ID: 31449843
[TBL] [Abstract][Full Text] [Related]
19. L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.
Papadopoulos EI; Petraki C; Gregorakis A; Chra E; Fragoulis EG; Scorilas A
Clin Biochem; 2015 Jun; 48(9):590-5. PubMed ID: 25721989
[TBL] [Abstract][Full Text] [Related]
20. Sequence and structure of the dopa decarboxylase gene of Drosophila: evidence for novel RNA splicing variants.
Eveleth DD; Gietz RD; Spencer CA; Nargang FE; Hodgetts RB; Marsh JL
EMBO J; 1986 Oct; 5(10):2663-72. PubMed ID: 3023054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
